Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology

BJU International

Volumn 103, Issue 10, 2009, Pages 1363-1367

  Ray, Eleanor R ^a   Chatterton, Kathryn ^a   Khan, Mohammed S ^a   Thomas, Kay ^a   Chandra, Ashish ^a   O'Brien, Tim S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Bladder; Blue light; Carcinoma; Cytology; Fluorescence; Hexvix

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; 5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; DIAGNOSTIC AGENT; DRUG DERIVATIVE; PHOTOSENSITIZING AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; DYSPLASIA; FEMALE; FLUORESCENCE; FOLLOW UP; HISTOLOGY; HUMAN; INTRAVENOUS UROGRAPHY; LIGHT; MALE; MEDICAL INSTRUMENTATION; PHOTODYNAMIC DIAGNOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; RETROGRADE PYELOGRAPHY; TRANSITIONAL CELL CARCINOMA; ULTRASOUND; URETEROSCOPY; URINE CYTOLOGY; BLADDER TUMOR; COHORT ANALYSIS; EVALUATION; FLUORESCENCE MICROSCOPY; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; CYSTOSCOPY; FEMALE; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 66149132681     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08238.x     Document Type: Article

References (16)

1. Schwalb DM, Herr HW, Fair WR. The management of clinically unconfirmed positive urinary cytology. J Urol 1993 150 : 1751 6
2. Kelly JF, Snell ME. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 1976 115 : 150 1
3. Zaak D, Kriegmair M, Stepp H et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology 2001 57 : 690 4
4. Kriegmair M, Baumgartner R, Knuechel R et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994 44 : 836 41
5. Lange N, Jichlinski P, Zellweger M et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 1999 80 : 185 93
6. Marti A, Lange N, van den Bergh H, Sedmera D, Jichlinski P, Kucera P. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol 1999 162 : 546 52
7. Jichlinski P, Guillou L, Karlsen SJ et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer - a multicenter study. J Urol 2003 170 : 226 9
8. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004 171 : 135 8
9. Jocham D, Witjes F, Wagner S et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005 174 : 862 6
10. Fradet Y, Grossman HB, Gomella L et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007 178 : 68 73
11. Grossman HB, Gomella L, Fradet Y et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007 178 : 62 7
12. Mostofi FK, Sobin LH, Torloni H. International Histological Classification of Tumours. Geneva : World Health Organisation, 1973
13. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 22 : 1435 48
14. Farrow GM. Pathologist's role in bladder cancer. Semin Oncol 1979 6 : 198 206
15. Raitanen MP, Aine R, Rintala E et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol 2002 41 : 284 9
16. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou J. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008 54 : 303 14